• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

TABLE 65Individual study event rates: Clavien I

StudyRobotic, n/N (%)Laparoscopic, n/N (%)Open, n/N (%)
Artibani 200312316/71 (22.5)3/50 (6.0)
Bhayani 20031242/33 (6.1)0/24 (0)
Brown 200412511/60 (18.3)4/60 (6.7)
Carlsson 201010437/1253 (3.0)83/485 (17.1)
Dahl 20091269/104 (8.7)0/102 (0)
Doumerc 20101051/212 (0.5)0/502 (0)
Drouin 20091012/71 (2.8)0/85 (0)
Fornara 20041270/32 (0)2/32 (6.3)
Fracalanza 20081072/35 (5.7)4/26 (15.4)
Ghavamian 20061283/70 (4.3)5/70 (7.1)
Guazzoni 20069010/60 (16.7)24/60 (40.0)
Hu 20069238/322 (11.8)69/358 (19.3)
Joseph 20079424/754 (3.2)160/800 (20.0)
Jurczok 20071315/163 (3.1)8/240 (3.3)
Kim 20071329/30 (30.0)0/45 (0)
Krambeck 200910813/294 (4.4)20/588 (3.4)
Lama 20091332/56 (3.6)7/59 (11.9)
Martorana 20041341/50 (2%)2/50 (4%)
Nadler 20101122/50 (4.0)2/50 (4.0)
Ou 20091130/30 (0)2/30 (6.7)
Poulakis 20071371/204 (0.5)1/70 (1.4)
Remzi 20051398/80 (10.0)6/41 (14.6)
Rozet 20079612/133 (9.0)7/133 (5.3)
Salomon 20021406/155 (3.9)14/151 (9.3)
Sundaram 2004971/10 (10.0)1/10 (10.0)
Tewari 20031160/200 (0)2/200 (1.0)

From: Appendix 10, Classification of reported adverse effects using the Clavien–Dindo classification of surgical complications

Cover of Systematic Review and Economic Modelling of the Relative Clinical Benefit and Cost-Effectiveness of Laparoscopic Surgery and Robotic Surgery for Removal of the Prostate in Men with Localised Prostate Cancer
Systematic Review and Economic Modelling of the Relative Clinical Benefit and Cost-Effectiveness of Laparoscopic Surgery and Robotic Surgery for Removal of the Prostate in Men with Localised Prostate Cancer.
Health Technology Assessment, No. 16.41.
Ramsay C, Pickard R, Robertson C, et al.
© 2012, Crown Copyright.

Included under terms of UK Non-commercial Government License.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.